New Head of Analytics to Help Healthcare Target Interventions for Better Outcomes

MedeAnalyticsA new head of analytics at the UK arm of MedeAnalytics, a pioneer in health analytics, is to help healthcare planners and frontline staff understand which patients, across their entire local population, are at risk of specific adverse events and what interventions will work for individual patients as a means of prevention.

Paul Molyneux, who has held posts at the Care Quality Commission (CQC), Cerner and Dr Foster, has joined a rapidly growing team of world-class specialists at MedeAnalytics in the UK. Working with areas like Hertfordshire, the team has helped health and social care organisations overcome information governance obstacles to create a joined-up health economy. The result is that for the first time, organisations can safely link and unlock their data for use across health and social care whilst still securely maintaining patient privacy.

Molyneux, who was once part of the Healthcare Commission team that uncovered statistical outliers related to the Mid Staffordshire scandal, will now work closely with clinical and epidemiological colleagues at MedeAnalytics and throughout health and care.

He will help to develop risk models that predict which interventions will prove successful for specific patients and that will allow resources to be targeted where they will work across populations.

Commenting on his appointment Molyneux said: "If you can measure something, you can manage it. MedeAnalytics has become the first to solve major governance obstacles to enable the safe sharing and use of information between authorised users across different care settings. I look forward to working with customers throughout the UK to help them unleash the power of that information by predicting where and when, across their health economy, they can have the maximum impact for patients. Crucially, this is about getting research onto the shop floor and into practice, in order to improve outcomes."

Molyneux's new role at MedeAnalytics follows a series of high profile appointments in the UK for the company, including Professor Simon Jones, former chief statistician at Dr Foster, and Dr Mark Davies, the former medical director at the Health and Social Care Information Centre.

Wayne Parslow, UK general manager at MedeAnalytics, said: "Having the right people in place with the right tools to respond to real NHS and healthcare challenges is crucial. Paul will work closely with Professor Jones and Dr Davies to hone new ideas on predictive analytics, with real clinical understanding, so that we can help local health economies deliver services that are truly focussed on achieving the most for individual patients across their population. This will herald a new era of targeted and more efficient health and social care.

"Combining these thought leaders, with the right technology, and working in collaboration with those on the frontline, will allow the NHS and social care to not only understand which patients are at risk, but where, when and how they can successfully intervene."

About MedeAnalytics
MedeAnalytics provides evidence-based insights to solve a real problem that plagues healthcare - how to use the immense amount of patient data collected along the care continuum to deliver cost-effective care and promote a healthier population. Its analytics platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics' cloud-based tools have been used to uncover business insights for nearly 1,000 healthcare organizations across the United States and United Kingdom. The company has also been named one of Modern Healthcare's top 100 Best Places to Work in Healthcare for 2014.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...